phenylacetic acid has been researched along with Cancer of Ovary in 2 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epithelial ovarian cancer is a major cause of cancer-related mortality in women, making the search for new treatment modalities essential." | 1.30 | Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines. ( Abbruzzese, JL; Ferrandina, G; Freedman, RS; Loercher, A; Melichar, B; Verschraegen, CF, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrandina, G | 2 |
| Melichar, B | 2 |
| Loercher, A | 2 |
| Verschraegen, CF | 2 |
| Kudelka, AP | 1 |
| Edwards, CL | 1 |
| Scambia, G | 1 |
| Kavanagh, JJ | 1 |
| Abbruzzese, JL | 2 |
| Freedman, RS | 2 |
2 other studies available for phenylacetic acid and Cancer of Ovary
| Article | Year |
|---|---|
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cisplatin; Cystadenocarcinoma, Serous; Dose-Response Rel | 1997 |
Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
Topics: Aminobutyrates; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molecules; Cell Divisi | 1998 |